Respiratory symptoms in palliative care;Síntomas respiratorios en cuidados paliativos

Atencion Primaria

Volumn 38, Issue SUPPL. 2, 2006, Pages 38-46

  Moralo, María José Redondo ^a   Pinna, Miguel Ángel Cuervo ^a  

^a HOSPITAL PERPETUO SOCORRO   (Spain)

Author keywords

Cough; Dyspnea; Hiccups; Malignant pleural effusion; Neoplasia

Indexed keywords

BENZODIAZEPINE; GABAPENTIN; HALOPERIDOL; MIDAZOLAM; MORPHINE; NIFEDIPINE; OPIATE;

ADVANCED CANCER; CANCER PATIENT; CATHETERIZATION; COUGHING; DYSPNEA; HICCUP; HUMAN; OUTCOME ASSESSMENT; OXYGEN THERAPY; PALLIATIVE THERAPY; PLEURA EFFUSION; PLEURODESIS; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; REVIEW; THORACOCENTESIS;

EID: 34547653568     PISSN: 02126567     EISSN: 15781275     Source Type: Journal    
DOI: 10.1157/13094774     Document Type: Review

References (52)

1. Meek PM, Schwartzstein RM, Adams L, Altose MD, Breslin EH, Carrieri-Kohlman V, et al. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159:321-40.
2. Derek D, Hanks G, Cherny N, Calman K. Oxford Textbook of Palliative Medicine. 3rd ed. New York: Oxford University Press; 2005.
3. Cuervo MA, Mota R, Redondo MJ, Sánchez MA. Prevalencia y etiopatogenia de la disnea en pacientes atendidos por un equipo de soporte de cuidados paliativos mixto. Programa Regional de Cuidados Paliativos. Servicio Extremeño de Salud. San Sebastián: Congreso Nacional de Cuidados Paliativos; junio de 2006.
4. Conill C, Verger E, Henríquez D, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage. 1997;14:328-31.
5. Pirovano M, Maltoni M, Nanni O, et al. A new palliative prognostic store: a first step for the staging of terminally ill cancer patients. J Pain Symptom Manage. 1999;17:231-9.
6. Cuervo MA, Mota R, Redondo MJ, Sánchez MA. La disnea en la enfermedad terminal, magnitud del problema. Programa Regional de Cuidados Paliativos. Servicio Extremeño de Salud. San Sebastián: Congreso Nacional de Cuidados Paliativos; junio de 2006.
7. Bruera E, Schmitz B, Pither J, Newman CM, Hanson J. The frecuency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage. 2000;21:373-9.
8. Heyse-Moore LH, Beynon T, Ross V. Does spirometry predict dyspnea in advanced cancer? Pal Med. 2000;14:189-95.
9. Kirkova J, Davis M, Walsh D, et al. Cancer symptom assessment instruments: A systematic review. JCO. 2006;9:1459-73.
10. Carrieri-Kohlman V, Dudgeon D. Multidimensional assesment of dyspnea. En: Dyspnoea in advanced care. Oxford: Oxford University Press; 2006.
11. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Development and validation of the Cancer Dyspnea Scale. A multidimensional, brief, self-rating scale. Br J Cancer. 2000;4:800-5.
12. Jennings A, Davies A, Higgins J, Gibbs J, Broadley K. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939-44.
13. Bruera E, Macmillan K, Pither J, MacDonald RN. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage. 1990;5:341-4.
14. Bruera E, MacEachern T, Ripamonti C, Hanson J. Subcutaneous morphine for dyspnea in patients cancer. Ann Intern Med. 1993;119:906-7.
15. Mazzocato C, Buclin T, Rapin C. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: A randomized doble-blind controlled trial. Ann Oncol. 1999;10:1511-4.
16. Allard P, Lamontagne C, Bernard P, Tremblay C. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. J Pain Symptom Manage. 1999;17:256-65.
17. Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME. Midazolam as adjunct therapy to morphine in the alleviation of severe Dyspnea perception in Patients with advanced cancer. J Pain Symptom Manage. 2006;31:38-47.
18. Benítez Rosario MA, Feria M. Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients. J Pain Symptom Manage. 2005;30:395-7.
19. Dudgeon D. Breathlessness in advanced cancer. En: Dyspnoea in advanced disease, a guide to clinical management. Oxford: Oxford University Press; 2006. p. 75-98.
20. O'Neill PA, Morton PB, Stark RD. Chlorpromazine - a especific effect on breathlessness? Br J Clin Pharmacol. 1985;19:793-7.
21. McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Manage. 1994;9:341-5.
22. Roberts C. Short burst oxigen therapy for relief of breathlessness in COPD. Thorax. 2004;59:638-40.
23. Spathis A, Wade R, Booth S. Oxygen in the palliation of breathlessness. En: Dyspnoea in advanced disease, a guide to clinical management. Oxford: Oxford University Press; 2006. p. 2006-36.
24. Booth S, Nelly M, Cox N, Adams L, Guz A. Does oxigen help dyspnoea in patients with cancer? Am J Respir Crit Care Med. 1996;153:1515-8.
25. Bruera E, Schoeller T, MacEachern T. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. J Pain Symptom Manage. 1992;7:365-8.
26. Bruera E, Stoutz N, Velasco-Leiva A, Scholler T, Hanson J. Effect of oxygen on dyspnoea in hypoxemic terminal cancer patients. Lancet. 1993;342:13-4.
27. Bruera E, Sweeney C, Willey J, Lynn J, Strasser F, Morice R, et al. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Pall Med. 2003;17:659-63.
28. Ahmedzai S, Laude E, Robertson A, Troy J, Vora V. A double-blind, randomized controlled phase 2 trial of Heliox28 gas mixture in lung cancer patients with dyspnea on exertion. Br J Cancer. 2004;90:366-71.
29. Carrie-Kohlman V. Non-pharmacological approaches. En: Booth S, Dudgeon D, editors. Dyspnoea in advanced disease. A guide to clinical management. 1st ed. New York: Oxford University Press; 2006. p. 171-203.
30. Shaw P, Agarwal R. Pleurodesis para los derrames pleurales malignos (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus. Oxford: Update Software; 2006:1. Disponible en: http://www.update-software.com [versión original: The Cochrane Library. 2006:1].
31. Chan KS, Sham M, Tse D, Thorsen AB. Palliative medicine in malignant respiratory diseases. En: Doyle D, Hanks G, Mac Donald N, editors. Textbook of palliative medicine. 3rd ed. Oxford: Oxford University Press; 2004. p. 589-92.
32. Cheng D, Rodríguez RM, Perkett EA, Rogers J, Bienvenu G, Lappalainen U, et al. Vascular endothelial growth factor in pleural fluid. Chest. 1999;116:760-5.
33. American Thoracic Society. Management of malignant pleural effusion. Am J Respir Crit Care Med. 2000;162:1987-2001.
34. Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic and quality of life measures of extent of disease. Chest. 2000;117:73-8.
35. Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and trasudative pleural effusions. Chest. 1997;111:970-80.
36. Walker-Renard P, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120:56-64.
37. Yildirim E, Dural K, Yazkan R, Zengin N, Yildirim D, Gunal N, et al. Rapid pleurodesis in symptomatic malignant pleural effusion. Eur J Cardiothoracic Surg. 2005;27:19-22.
38. Turler A, Gawenda M, Walter M. Palliative iodized talc pleurodesis with instillation via tube thoracostomy. Support Care Cancer. 1997;5:61-3.
39. Tremblay A, Michaud G. Single-center experience with 250 tunelled pleural catheter insertions for malignant pleural effusion. Chest. 2006;129:362-8.
40. Porcel Pérez JM. Tratamiento paliativo del derrame pleural maligno. Med Pal. 2003;10:142-8.
41. Putnam JB Jr, Light RW, Rodríguez RM, Ponn R, Olak J, Pollak JS, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86:1992-9.
42. Petrou M, Kaplan D, Goldstraw P. Management of recurrent malignant pleural effusion. The complementary rol talc pleurodesis and pleuroperitoneal shunting. Cancer. 1995;75:801-5.
43. Soysal O, Karaoglanoglu N, Demiracan S, Topcu S, Tastepe I, Kaya S, et al. Pleurectomy/decortication for palliation in malignant pleural mesothelioma: Results of surgery. Eur J Cardiothorac Surg. 1997;11: 210-3.
44. Chan KS, Sham M, Tse D, Thorsen AB. Palliative medicine in malignant respiratory diseases. Cough in cancer patients. En: Doyle D, Hanks G, Mac Donald N, editors. Textbook of palliative medicine. 3rd ed. Oxford: Oxford University Press; 2004.
45. French CL, Irwin RS, Curley FJ, Krikorian CJ. Impact of chronic cough on quality of life. Arch Intern Med. 1998;158:1657-61.
46. Cowcher K, Hanks GW. Long-term management of respiratory symptoms in advanced cancer. J Pain Symptom Manage. 1990;5:320-30.
47. Hagen NA. An approach to cough in cancer patients. J Pain Symptom Manage. 1991;6:257-62.
48. Louie K, Bertolino M, Fainsinger R. Management of intractable cough. J Palliat Care. 1992;8:46-8.
49. Rousseau P. Hiccups in terminal disease. Am J Hosp Palliat Care. 1994;11:7-10.
50. Howard RS. Persistent hiccups. BMJ. 1992;305:1237-8.
51. Ramírez FC, Graham DY. Treatment of intractable hiccup with baclofen: results of a double-blind randomized, cross-over study. Am J Gastroenterol. 1992;87:1789-91.
52. Wilcock A, Twycross R. Midazolam for intractable hiccup (singultus). J Pain Symtom Manage. 1997;12:59-61.